Five men with arresting and relapsing cerebral adrenoleukodystrophy.

ALD (adrenoleukodystrophy) Demyelinating diseases Hematopoietic stem-cell transplantation Leukoencephalopathy Peroxisomal disorders

Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 04 06 2020
accepted: 11 09 2020
revised: 09 09 2020
pubmed: 1 10 2020
medline: 22 6 2021
entrez: 30 9 2020
Statut: ppublish

Résumé

X-linked adrenoleukodystrophy (ALD) is the most common genetic peroxisomal disorder with an estimated prevalence of 1:15,000. Approximately two-thirds of males with ALD manifest the inflammatory demyelinating cerebral phenotype (cALD) at some disease stage, in which focal, inflammatory lesions progress over months to years. Hematopoietic stem-cell transplantation can permanently halt cALD progression, but it is only effective if initiated early. Although most cALD lesions progress relentlessly, a subset may spontaneously arrest; subsequent reactivation of these arrested lesions has not been previously detailed. We describe a novel arresting-relapsing variant of cALD. Salient clinical and radiographic studies were reviewed and summarized for cALD patients with episodic deteriorations. We report a series of five unrelated men with spontaneously arrested cALD lesions that subsequently manifested signs of clinical and radiologic lesion progression during longitudinal follow-up. In three of five patients, functional status was too poor to attempt transplant by the time the recurrence was identified. One patient experienced reactivation followed by another period of spontaneous arrest. These cases emphasize the need for continued clinical and radiologic vigilance for adult men with ALD to screen for evidence of new or reactivated cALD lesions to facilitate prompt treatment evaluation.

Sections du résumé

BACKGROUND BACKGROUND
X-linked adrenoleukodystrophy (ALD) is the most common genetic peroxisomal disorder with an estimated prevalence of 1:15,000. Approximately two-thirds of males with ALD manifest the inflammatory demyelinating cerebral phenotype (cALD) at some disease stage, in which focal, inflammatory lesions progress over months to years. Hematopoietic stem-cell transplantation can permanently halt cALD progression, but it is only effective if initiated early. Although most cALD lesions progress relentlessly, a subset may spontaneously arrest; subsequent reactivation of these arrested lesions has not been previously detailed.
OBJECTIVE OBJECTIVE
We describe a novel arresting-relapsing variant of cALD.
METHODS METHODS
Salient clinical and radiographic studies were reviewed and summarized for cALD patients with episodic deteriorations.
RESULTS RESULTS
We report a series of five unrelated men with spontaneously arrested cALD lesions that subsequently manifested signs of clinical and radiologic lesion progression during longitudinal follow-up. In three of five patients, functional status was too poor to attempt transplant by the time the recurrence was identified. One patient experienced reactivation followed by another period of spontaneous arrest.
CONCLUSIONS CONCLUSIONS
These cases emphasize the need for continued clinical and radiologic vigilance for adult men with ALD to screen for evidence of new or reactivated cALD lesions to facilitate prompt treatment evaluation.

Identifiants

pubmed: 32995952
doi: 10.1007/s00415-020-10225-7
pii: 10.1007/s00415-020-10225-7
pmc: PMC8025682
mid: NIHMS1685697
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

936-940

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS087151
Pays : United States

Références

J Neurol Sci. 2010 Mar 15;290(1-2):70-4
pubmed: 19945717
Blood. 2011 Aug 18;118(7):1971-8
pubmed: 21586746
Neurology. 2019 Apr 9;92(15):e1698-e1708
pubmed: 30902905
Arch Neurol. 2007 May;64(5):659-64
pubmed: 17502464
Neuropathol Appl Neurobiol. 2014 Aug;40(5):658-61
pubmed: 24117509
Neurology. 2014 Dec 9;83(24):2227-31
pubmed: 25378668
Ann Neurol. 2001 Feb;49(2):186-94
pubmed: 11220738
Orphanet J Rare Dis. 2012 Aug 13;7:51
pubmed: 22889154
Biochimie. 2014 Mar;98:135-42
pubmed: 24316281

Auteurs

Aaron M Carlson (AM)

Department of Neurology, University of Colorado, Denver, CO, USA.

Irene C Huffnagel (IC)

Department of Pediatric Neurology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Aad Verrips (A)

Department of Neurology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.

Marjo S van der Knaap (MS)

Department of Pediatric Neurology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Marc Engelen (M)

Department of Pediatric Neurology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Keith Van Haren (K)

Department of Pediatric Neurology, Lucille-Packard Children's Hospital, Stanford University School of Medicine, Stanford, CA, USA. kpv@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH